Establishment Labs Holdings Inc. (ESTA)
NASDAQ: ESTA · Real-Time Price · USD
63.35
-0.25 (-0.39%)
At close: Mar 13, 2026, 4:00 PM EDT
63.36
0.00 (0.01%)
After-hours: Mar 13, 2026, 5:50 PM EDT

Company Description

Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for breast aesthetic and reconstructive plastic surgeries in Europe, the Middle East, Africa, Latin America, Asia, and the United States.

The company offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides breast tissue expanders.

The company sells products to physicians, hospitals, and clinics through distributors and its direct sales force.

Establishment Labs Holdings Inc. was incorporated in 2004 and is based in Austin, Texas.

Establishment Labs Holdings Inc.
Establishment Labs Holdings logo
CountryUnited States
Founded2004
IPO DateJul 19, 2018
IndustryMedical Devices
SectorHealthcare
Employees1,023
CEOFillipo Caldini

Contact Details

Address:
11401 century oaks terrace, suite 400
Austin, Texas 78758
United States
Phone800 924 5072
Websiteestablishmentlabs.com

Stock Details

Ticker SymbolESTA
ExchangeNASDAQ
Fiscal YearJanuary - December
Reporting CurrencyUSD
CIK Code0001688757
CUSIP NumberG31249108
ISIN NumberVGG312491084
Employer ID98-1436377
SIC Code3842

Key Executives

NamePosition
Fillipo Peter CaldiniChief Executive Officer and Director
Juan Jose Chacon QuirosFounder and Executive Director
S. Ross MansbachGeneral Counsel, Chief Compliance Officer and Chief Human Resources Officer
Roberto de MezervilleChief Technology Officer
Ivan BilicSenior Vice President of Commercial Operations - OUS
Jeff EhrhardtSenior Vice President and GM of North America

Latest SEC Filings

DateTypeTitle
Feb 27, 2026S-8Securities to be offered to employees in employee benefit plans
Feb 27, 202610-KAnnual Report
Feb 24, 20268-KCurrent Report
Feb 19, 2026SCHEDULE 13G/AFiling
Feb 13, 2026SCHEDULE 13G/AFiling
Feb 13, 2026SCHEDULE 13G/AFiling
Jan 14, 20268-KCurrent Report
Jan 12, 20268-KCurrent Report
Nov 14, 2025SCHEDULE 13G/AFiling
Nov 7, 202510-QQuarterly Report